* Humanigen Inc HGEN.OQ HGEN.O is expected to report
results on August 12 (estimated).
* The Burlingame, California-based company is expected to report
revenue of $35.976 million, according to the mean estimate from
5 analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Humanigen Inc is for a
loss of 86 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Humanigen Inc
is $33.5, about 47.5% above its last closing price
of $17.60.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Mar. 31 2021 -0.71 -0.64 -1.25 Missed -95.3
Dec. 31 2020 -0.68 -0.67 -0.63 Beat 6.3
Sep. 30 2020 -0.57 -0.57 -0.71 Missed -25.3
This summary was machine generated August 10 at 23:35 GMT. All
figures in US dollars unless otherwise stated